Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling*
暂无分享,去创建一个
G. Milligan | A. Tobin | A. Inoue | E. Alvarez-Curto | S. Raihan | Laura Jenkins | R. Prihandoko | Elisa Alvarez-Curto
[1] B. Hudson,et al. Complex Pharmacology of Free Fatty Acid Receptors. , 2017, Chemical reviews.
[2] B. Hudson,et al. Syddansk Universitet Complex Pharmacology of Free Fatty Acid Receptors , 2017 .
[3] Wen-long Huang,et al. Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development , 2016, Expert opinion on investigational drugs.
[4] Ashley M. Miller,et al. Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein–Coupled Receptor 120 , 2016, Molecular Pharmacology.
[5] G. Lin,et al. Potential pitfalls of CRISPR/Cas9‐mediated genome editing , 2016, The FEBS journal.
[6] S. Nuber,et al. β-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle , 2016, Nature.
[7] S. Rajagopal,et al. The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors* , 2016, The Journal of Biological Chemistry.
[8] A. Tobin,et al. An Antibody Biosensor Establishes the Activation of the M1 Muscarinic Acetylcholine Receptor during Learning and Memory*♦ , 2016, The Journal of Biological Chemistry.
[9] H. Dohlman,et al. The experimental power of FR900359 to study Gq-regulated biological processes , 2015, Nature Communications.
[10] A. Shukla,et al. Emerging Functional Divergence of β-Arrestin Isoforms in GPCR Function , 2015, Trends in Endocrinology & Metabolism.
[11] C. Chavkin,et al. Mu opioid receptor stimulation activates c-Jun N-terminal kinase 2 by distinct arrestin-dependent and independent mechanisms. , 2015, Cellular signalling.
[12] B. Hudson,et al. Characterizing pharmacological ligands to study the long‐chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4 , 2015, British journal of pharmacology.
[13] V. Gurevich,et al. Arrestins: Critical Players in Trafficking of Many GPCRs. , 2015, Progress in molecular biology and translational science.
[14] F. Zhang,et al. CRISPR/Cas9 for genome editing: progress, implications and challenges. , 2014, Human molecular genetics.
[15] B. Hudson,et al. The Molecular Basis of Ligand Interaction at Free Fatty Acid Receptor 4 (FFA4/GPR120)* , 2014, The Journal of Biological Chemistry.
[16] B. Hudson,et al. Concomitant Action of Structural Elements and Receptor Phosphorylation Determines Arrestin-3 Interaction with the Free Fatty Acid Receptor FFA4* , 2014, The Journal of Biological Chemistry.
[17] L. Bohn,et al. Functional selectivity of GPCR signaling in animals. , 2014, Current opinion in cell biology.
[18] N. Morgan,et al. GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans , 2014, Diabetologia.
[19] Ilya Senatorov,et al. Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr³⁴⁷, Ser³⁵⁰, and Ser³⁵⁷ in the C-terminal tail. , 2014, Biochemical pharmacology.
[20] G. Schulte,et al. β-Arrestin Promotes Wnt-induced Low Density Lipoprotein Receptor-related Protein 6 (Lrp6) Phosphorylation via Increased Membrane Recruitment of Amer1 Protein* , 2013, The Journal of Biological Chemistry.
[21] B. Hudson,et al. The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism , 2013, Molecular Pharmacology.
[22] R. Lefkowitz,et al. A brief history of G-protein coupled receptors (Nobel Lecture). , 2013, Angewandte Chemie.
[23] John T. Williams,et al. Increased Agonist Affinity at the μ-Opioid Receptor Induced by Prolonged Agonist Exposure , 2013, The Journal of Neuroscience.
[24] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[25] B. Hudson,et al. Discovery of a potent and selective GPR120 agonist. , 2012, Journal of medicinal chemistry.
[26] K. Dalby,et al. The Effect of Arrestin Conformation on the Recruitment of c-Raf1, MEK1, and ERK1/2 Activation , 2011, PloS one.
[27] V. Gurevich,et al. A single mutation in arrestin-2 prevents ERK1/2 activation by reducing c-Raf1 binding. , 2011, Biochemistry.
[28] H. Subramanian,et al. Distinct and Shared Roles of β-Arrestin-1 and β-Arrestin-2 on the Regulation of C3a Receptor Signaling in Human Mast Cells , 2011, PloS one.
[29] T. Hakoshima,et al. Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule , 2010, Proceedings of the National Academy of Sciences.
[30] L. Luttrell,et al. Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling , 2010, Pharmacological Reviews.
[31] L. Bohn,et al. Physiological and pharmacological implications of beta-arrestin regulation. , 2009, Pharmacology & therapeutics.
[32] Leigh A. Stoddart,et al. Conserved Polar Residues in Transmembrane Domains V, VI, and VII of Free Fatty Acid Receptor 2 and Free Fatty Acid Receptor 3 Are Required for the Binding and Function of Short Chain Fatty Acids* , 2008, Journal of Biological Chemistry.
[33] Jeffrey L. Benovic,et al. M3 Muscarinic Acetylcholine Receptor-Mediated Signaling Is Regulated by Distinct Mechanisms , 2008, Molecular Pharmacology.
[34] H. Kovacic,et al. G␣(q/11)-coupled P2y 2 Nucleotide Receptor Inhibits Human Keratinocyte Spreading and Migration , 2022 .
[35] Pascale G. Charest,et al. The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling. , 2007, Cellular signalling.
[36] G. Milligan,et al. Up-regulation of the Angiotensin II Type 1 Receptor by the MAS Proto-oncogene Is Due to Constitutive Activation of Gq/G11 by MAS* , 2006, Journal of Biological Chemistry.
[37] R. Lefkowitz,et al. Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation* , 2006, Journal of Biological Chemistry.
[38] G. Milligan,et al. Heterotrimeric G‐proteins: a short history , 2006, British journal of pharmacology.
[39] Olivier Lichtarge,et al. β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor* , 2006, Journal of Biological Chemistry.
[40] Shelagh Wilson,et al. The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation. , 2005, The Biochemical journal.
[41] M. Taniguchi,et al. A Novel Gαq/11-selective Inhibitor* , 2004, Journal of Biological Chemistry.
[42] R. Lefkowitz,et al. Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[43] P. M. Hinkle,et al. Signal Transduction and Hormone-dependent Internalization of the Thyrotropin-releasing Hormone Receptor in Cells Lacking Gq and G11 * , 1999, The Journal of Biological Chemistry.
[44] Melvin I. Simon,et al. Members of the Gq alpha subunit gene family activate phospholipase C beta isozymes. , 1992, The Journal of biological chemistry.